BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23777771)

  • 1. Association of iron overload with allogeneic hematopoietic cell transplantation outcomes: a prospective cohort study using R2-MRI-measured liver iron content.
    Trottier BJ; Burns LJ; DeFor TE; Cooley S; Majhail NS
    Blood; 2013 Aug; 122(9):1678-84. PubMed ID: 23777771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
    Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of iron overload management in allogeneic hematopoietic cell transplantation survivors.
    Majhail NS; Lazarus HM; Burns LJ
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):832-7. PubMed ID: 20079863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors.
    Majhail NS; DeFor T; Lazarus HM; Burns LJ
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):790-4. PubMed ID: 18541198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI-based liver iron content predicts for nonrelapse mortality in MDS and AML patients undergoing allogeneic stem cell transplantation.
    Wermke M; Schmidt A; Middeke JM; Sockel K; von Bonin M; Schönefeldt C; Mair S; Plodeck V; Laniado M; Weiss G; Schetelig J; Ehninger G; Theurl I; Bornhäuser M; Platzbecker U
    Clin Cancer Res; 2012 Dec; 18(23):6460-8. PubMed ID: 22991415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron overload in allogeneic hematopoietic cell transplantation outcome: a meta-analysis.
    Armand P; Kim HT; Virtanen JM; Parkkola RK; Itälä-Remes MA; Majhail NS; Burns LJ; DeFor T; Trottier B; Platzbecker U; Antin JH; Wermke M
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1248-51. PubMed ID: 24769316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Hepatic Iron Content Predicts Poor Survival in Patients With Iron Overload Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation.
    Sivgin S; Baldane S; Deniz K; Zararsiz G; Kaynar L; Cetin M; Unal A; Eser B
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S10-8. PubMed ID: 27521305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum ferritin is not a reliable predictor to determine iron overload in thalassemia major patients post-hematopoietic stem cell transplantation.
    Jarisch A; Salzmann-Manrique E; Cario H; Grosse R; Soerensen J; Fischer R; Schulz A; Hammerstingl R; Wunderlich A; Bader P
    Eur J Haematol; 2018 Dec; 101(6):791-797. PubMed ID: 30187571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperferritinemia after adult allogeneic hematopoietic cell transplantation: quantification of iron burden by determining non-transferrin-bound iron.
    Goto T; Ikuta K; Inamoto Y; Kamoshita S; Yokohata E; Koyama D; Onodera K; Seto A; Watanabe K; Imahashi N; Tsukamoto S; Ozawa Y; Sasaki K; Ito M; Kohgo Y; Miyamura K
    Int J Hematol; 2013 Jan; 97(1):125-34. PubMed ID: 23264147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective Evaluation of Relationship Between Iron Overload and Transplantation Complications in Pediatric Patient Who Underwent Allogeneic Stem Cell Transplantation Due to Acute Leukemia and Myelodysplastic Syndrome.
    Küpesiz FT; Hazar V; Eker N; Guler E; Yesilipek MA; Tuysuz G; Kupesiz A
    J Pediatr Hematol Oncol; 2020 Jul; 42(5):e315-e320. PubMed ID: 32427707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification by magnetic resonance imaging and liver consequences of post-transfusional iron overload alone in long term survivors after allogeneic hematopoietic stem cell transplantation (HSCT).
    Rose C; Ernst O; Hecquet B; Maboudou P; Renom P; Noel MP; Yakoub-Agha I; Bauters F; Jouet JP
    Haematologica; 2007 Jun; 92(6):850-3. PubMed ID: 17550861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Kamble RT; Selby GB; Mims M; Kharfan-Dabaja MA; Ozer H; George JN
    Biol Blood Marrow Transplant; 2006 May; 12(5):506-10. PubMed ID: 16635785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretransplant serum ferritin level may be a predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation.
    Sivgin S; Baldane S; Kaynar L; Kurnaz F; Pala C; Ozturk A; Cetin M; Unal A; Eser B
    Neoplasma; 2012; 59(2):183-90. PubMed ID: 22248276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron overload in hematopoietic cell transplantation.
    Majhail NS; Lazarus HM; Burns LJ
    Bone Marrow Transplant; 2008 Jun; 41(12):997-1003. PubMed ID: 18438425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging diagnosis of iron overload in a leukemic patient after allogeneic hematopoietic stem cell transplantation.
    Tan CH; Marcal L; Tan D; Patnana M
    Transfusion; 2010 May; 50(5):1113-7. PubMed ID: 20070618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation.
    Armand P; Kim HT; Rhodes J; Sainvil MM; Cutler C; Ho VT; Koreth J; Alyea EP; Hearsey D; Neufeld EJ; Fleming MD; Steen H; Anderson D; Kwong RY; Soiffer RJ; Antin JH
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):852-60. PubMed ID: 20854920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-Energy CT for Patients Suspected of Having Liver Iron Overload: Can Virtual Iron Content Imaging Accurately Quantify Liver Iron Content?
    Luo XF; Xie XQ; Cheng S; Yang Y; Yan J; Zhang H; Chai WM; Schmidt B; Yan FH
    Radiology; 2015 Oct; 277(1):95-103. PubMed ID: 25880263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced labile plasma iron and outcome in acute myeloid leukaemia and myelodysplastic syndrome after allogeneic haemopoietic cell transplantation (ALLIVE): a prospective, multicentre, observational trial.
    Wermke M; Eckoldt J; Götze KS; Klein SA; Bug G; de Wreede LC; Kramer M; Stölzel F; von Bonin M; Schetelig J; Laniado M; Plodeck V; Hofmann WK; Ehninger G; Bornhäuser M; Wolf D; Theurl I; Platzbecker U
    Lancet Haematol; 2018 May; 5(5):e201-e210. PubMed ID: 29628397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation.
    Pullarkat V; Blanchard S; Tegtmeier B; Dagis A; Patane K; Ito J; Forman SJ
    Bone Marrow Transplant; 2008 Dec; 42(12):799-805. PubMed ID: 18762767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of liver iron concentration by superconducting quantum interference device biomagnetic liver susceptometry validates serum ferritin as prognostic parameter for allogeneic stem cell transplantation.
    Jacobi N; Herich L
    Eur J Haematol; 2016 Oct; 97(4):336-41. PubMed ID: 26800433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.